Literature DB >> 1939642

Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura.

D J O'Donoghue1, A Darvill, F W Ballardie.   

Abstract

The autoantigen(s) that we have previously described in human glomeruli, recognized in IgA nephropathy, has (have) been identified as mesangial cell in origin. Cultured mesangial cells expressed 48- and 55-kD components binding IgG isotype autoantibodies (IgG-MESCA) present in sera of patients with both IgA nephropathy and Henoch-Schönlein purpura (HSP). IgG-MESCA were not detected in sera of normals, or patients with other autoimmune-mediated glomerulonephritides: anti-glomerular basement membrane disease, Wegener's granulomatosis, or in IgM-mesangial proliferative disease. Binding specificity was proven by F(ab')2 studies in enzyme-linked immunosorbent assay (ELISA) and Western blotting, and there was no significant affinity of IgA or IgM immunoglobulins. Fluorescein isothiocyanate-conjugated IgG from ELISA-positive sera localized to the mesangium and peripheral capillary loops of glomeruli, supporting the belief that the antigen is expressed in normal human renal tissue. However, only about one third of mesangial cells in culture showed affinity for IgG from ELISA-positive sera, suggesting variable expression of the antigen(s) in vitro. The only autoantigen(s) present in glomeruli, and extractable from whole normal glomeruli by the techniques employed, localized on the mesangial cell. In both IgA nephropathy and HSP, autoimmunity was intermittently present, with fluctuating levels of IgG-MESCA detectable in sera. There were positive correlations with the degree of glomerular injury assessed by erythrocyturia and proteinuria in IgA nephropathy, but significance was reached with only the degree of hematuria in HSP. These findings suggest a contributing role in the pathogenesis of the mesangial proliferative lesions and demonstrate autoimmunity common to both IgA nephropathy and HSP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939642      PMCID: PMC295661          DOI: 10.1172/JCI115462

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound, IgA.

Authors:  M W Russell; B Mansa
Journal:  Scand J Immunol       Date:  1989-08       Impact factor: 3.487

2.  [Intercapillary deposits of IgA-IgG].

Authors:  J Berger; N Hinglais
Journal:  J Urol Nephrol (Paris)       Date:  1968-09

Review 3.  Glomerular cell culture.

Authors:  G E Striker; L J Striker
Journal:  Lab Invest       Date:  1985-08       Impact factor: 5.662

4.  Schönlein-Henoch syndrome in adults.

Authors:  D A Roth; D R Wilz; G B Theil
Journal:  Q J Med       Date:  1985-05

Review 5.  The role of antibody in the activation of the alternative complement pathway.

Authors:  W D Ratnoff; D T Fearon; K F Austen
Journal:  Springer Semin Immunopathol       Date:  1983

6.  IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms.

Authors:  J M Griffiss; D K Goroff
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

7.  Berger disease: Henoch-Schönlein syndrome without the rash.

Authors:  S R Meadow; D G Scott
Journal:  J Pediatr       Date:  1985-01       Impact factor: 4.406

8.  The clinical course of mesangial IgA associated nephropathy in adults.

Authors:  K M Nicholls; K F Fairley; J P Dowling; P Kincaid-Smith
Journal:  Q J Med       Date:  1984

9.  IGA mesangial glomerulonephritis; significance and pathogenesis of segmental-focal glomerular lesions.

Authors:  G Syré
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

10.  Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients.

Authors:  G D'Amico; E Imbasciati; G Barbiano Di Belgioioso; S Bertoli; G Fogazzi; F Ferrario; G Fellin; A Ragni; G Colasanti; L Minetti
Journal:  Medicine (Baltimore)       Date:  1985-01       Impact factor: 1.889

View more
  11 in total

Review 1.  Transforming growth factor-beta in disease: the dark side of tissue repair.

Authors:  W A Border; E Ruoslahti
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

Review 2.  Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; A Boldt; U Sack; J Fahnert
Journal:  Clin Exp Immunol       Date:  2016-09-08       Impact factor: 4.330

3.  Autoantibodies from mixed cryoglobulinaemia patients bind glomerular antigens.

Authors:  M P Dolcher; B Marchini; A Sabbatini; G Longombardo; C Ferri; L Riente; S Bombardieri; P Migliorini
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

4.  Alteration of lung diffusion capacity in IgA nephropathy.

Authors:  S Ravilly; M Chaussain; J L Iniguez; A Lenhert; G Kalifa; P Brun; P Niaudet; D Gendrel
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

5.  Characterization of anti-mesangial cell antibodies and their target antigens in patients with lupus nephritis.

Authors:  Hui Du; Min Chen; Ying Zhang; Ming-Hui Zhao
Journal:  J Clin Immunol       Date:  2005-05       Impact factor: 8.317

6.  Non-DNA-binding antibodies in patients with lupus nephritis could recognize membrane proteins of glomerular mesangial cells.

Authors:  Hui Du; Min Chen; Ying Zhang; Ming-Hui Zhao
Journal:  J Clin Immunol       Date:  2006-04-18       Impact factor: 8.317

Review 7.  Mesangial cells in the pathogenesis of progressive glomerular disease in animal models.

Authors:  J Floege; R J Johnson; W G Couser
Journal:  Clin Investig       Date:  1992-09

8.  Low antibody affinity restricted to the IgA isotype in IgA nephropathy.

Authors:  L Layward; A C Allen; J M Hattersley; S J Harper; J Feehally
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

9.  Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis.

Authors:  J Floege; E Eng; V Lindner; C E Alpers; B A Young; M A Reidy; R J Johnson
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

10.  IgA Structure Variations Associate with Immune Stimulations and IgA Mesangial Deposition.

Authors:  Zeliha Oruc; Christelle Oblet; Ahmed Boumediene; Anne Druilhe; Virginie Pascal; Elisabeth Le Rumeur; Armelle Cuvillier; Chahrazed El Hamel; Sandrine Lecardeur; Tomas Leanderson; Willy Morelle; Jocelyne Demengeot; Jean-Claude Aldigier; Michel Cogné
Journal:  J Am Soc Nephrol       Date:  2016-01-29       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.